Veracyte
VCYT
Veracyte (VCYT) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.54
- EPS estimate
- $0.43
- EPS surprise
- +26.20%
- Revenue surprise
- +3.96%
- Revenue
- $150.3M
- Revenue estimate
- $144.6M
- Reported
- Jul 30, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 30, 2026 | $0.43 | $0.54 | +26.20% | $150.3M | SEC |
| Q1 2026 | May 5, 2026 | $0.33 | $0.52 | +55.27% | $139.1M | SEC |
| Q4 2025 | Feb 25, 2026 | $0.41 | $0.53 | +29.52% | $140.6M | SEC |
| Q3 2025 | Nov 4, 2025 | $0.32 | $0.51 | +59.13% | $131.9M | SEC |
| Q2 2025 | Aug 6, 2025 | $0.28 | $0.44 | +57.65% | $130.2M | SEC |
| Q1 2025 | May 7, 2025 | $0.12 | $0.31 | +151.83% | $114.5M | SEC |
| Q4 2024 | Feb 24, 2025 | $0.11 | $0.06 | −47.04% | $118.6M | SEC |
| Q3 2024 | Nov 6, 2024 | $0.03 | $0.19 | +486.42% | $115.9M | SEC |
| Q2 2024 | Aug 6, 2024 | −$0.02 | $0.07 | +526.83% | $114.4M | SEC |
| Q1 2024 | May 7, 2024 | −$0.16 | −$0.02 | +87.42% | $96.8M | SEC |
| Q4 2023 | Feb 22, 2024 | −$0.10 | −$0.39 | −288.45% | $98.2M | SEC |
| Q3 2023 | Nov 7, 2023 | −$0.15 | −$0.41 | −179.86% | $90.1M | SEC |
| Q2 2023 | Aug 8, 2023 | −$0.15 | −$0.12 | +21.26% | $90.3M | SEC |
| Q1 2023 | May 4, 2023 | −$0.13 | −$0.11 | +18.22% | $82.4M | SEC |
| Q4 2022 | Feb 22, 2023 | −$0.15 | −$0.05 | +66.91% | $80.3M | SEC |
| Q3 2022 | Nov 2, 2022 | −$0.26 | −$0.12 | +53.54% | $75.6M | SEC |
| Q2 2022 | Aug 2, 2022 | −$0.22 | −$0.13 | +41.68% | $72.9M | SEC |
| Q1 2022 | May 3, 2022 | −$0.23 | −$0.20 | +13.72% | $67.8M | SEC |
| Q4 2021 | Feb 28, 2022 | −$0.16 | −$0.15 | +6.60% | $67.3M | SEC |
| Q3 2021 | Nov 9, 2021 | −$0.17 | −$0.20 | −17.65% | $60.4M | SEC |
Quarterly revenue
Frequently asked questions
When did Veracyte (VCYT) last report earnings?
Veracyte last reported on Jul 30, 2026, covering fiscal Q2 2026.
Did VCYT beat earnings estimates?
Yes. Veracyte reported EPS of $0.54 for Q2 2026 against a $0.43 estimate — a 26.20% beat.
How much revenue did VCYT report last quarter?
Veracyte reported $150.3M in revenue for Q2 2026, against a consensus estimate of $144.6M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.